Javier Muñoz Luque

Mr. Javier Muñoz Luque


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AHAmelia Hessheimer
Amelia Hessheimer
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
LMLilia Martínez de la Maza
Lilia Martínez de la Maza
JLJavier Muñoz Luque
Javier Muñoz Luque
MVMarina Vendrell
Marina Vendrell
CFConstantino Fondevila
Constantino Fondevila
Liver resection treats primary and secondary liver tumors, though clinical applicability is limited by the remnant liver mass and quality. Herein, major hepatic resections were performed in pigs to define changes associated with sufficient and insufficient remnants and improve liver-specific outcomes with somatostatin therapy. Three experimental groups were performed: 75% hepatectomy (75H), 90% hepatectomy (90H), and 90% hepatectomy + somatostatin (90H + SST). Animals were followed for 24 h (N = 6) and 5 d (N = 6). After hepatectomy, portal pressure gradient was higher in 90H versus 75H and 90H + SST (8 (3–13) mmHg vs. 4 (2–6) mmHg and 4 (2–6) mmHg, respectively, p < 0.001). After 24 h, changes were observed in 90H associated with stellate cell activation and collapse of sinusoidal lumen. Collagen chain type 1 alpha 1 mRNA expression was higher, extracellular matrix width less, and percentage of collagen-staining areas greater at 24 h in 90H versus 75H and 90H + SST. After 5 d, remnant liver mass was higher in 75H and 90H + SST versus 90H, and Ki-67 immunostaining was higher in 90H + SST versus 75H and 90H. As well, more TUNEL-staining cells were observed in 90H versus 75H and 90H + SST at 5 d. Perioperative somatostatin modified portal pressure, injury, apoptosis, and stellate cell activation, stemming changes related to hepatic fibrogenesis seen in liver remnants not receiving treatment.

30 December 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
SRSoraya Rodríguez
Soraya Rodríguez
AIAlicia Izquierdo
Alicia Izquierdo
JLJavier Muñoz Luque
Javier Muñoz Luque
PBPaula P. Burgos
Paula P. Burgos
CFConstantino Fondevila
Constantino Fondevila
Ex situ normothermic machine perfusion (NMP) of the liver has emerged as a dynamic preservation strategy, enabling the maintenance of metabolic activity and assessment of grafts prior to transplantation. Prolonged perfusions, however, are limited by the accumulation of metabolic waste, electrolyte imbalances, and inflammatory mediators that can compromise graft function. Continuous renal replacement therapies (CRRT), especially continuous venovenous hemodiafiltration (CVVHDF), offer a potential means to support solute clearance and homeostatic regulation during extended perfusion periods. In this protocol, we describe a reproducible and safe method for integrating CVVHDF into an ex situ liver NMP system by connecting the filtration circuit independently from the main organ perfusion circuit. This configuration supports hemodynamic stability, helps prevent excessive intravascular pressures, and may reduce the risk of tissue edema. The physical connection, priming, and monitoring of the CRRT circuit are explained in detail, along with instructions on how to utilize a Hoffman clamp to simulate physiological venous pressure. When compared to direct in-line circuit integration, representative results suggest that the out-of-circuit approach is associated with reduced graft edema, while maintaining stable circuit pressure and solute clearance. This approach can be easily integrated into other similar perfusion devices in order to improve solute handling while maintaining stable perfusion dynamics.

31 December 2025
Verified
Dataset
Closed access
PDF file
JLJordi Vengohechea Llorens
Jordi Vengohechea Llorens
SRSoraya Rodríguez
Soraya Rodríguez
AIAlicia Izquierdo
Alicia Izquierdo
JLJavier Muñoz Luque
Javier Muñoz Luque
PBPaula P. Burgos
Paula P. Burgos
CFConstantino Fondevila
Constantino Fondevila
Ex situ normothermic machine perfusion (NMP) of the liver has emerged as a dynamic preservation strategy, enabling the maintenance of metabolic activity and assessment of grafts prior to transplantation. Prolonged perfusions, however, are limited by the accumulation of metabolic waste, electrolyte imbalances, and inflammatory mediators that can compromise graft function. Continuous renal replacement therapies (CRRT), especially continuous venovenous hemodiafiltration (CVVHDF), offer a potential means to support solute clearance and homeostatic regulation during extended perfusion periods. In this protocol, we describe a reproducible and safe method for integrating CVVHDF into an ex situ liver NMP system by connecting the filtration circuit independently from the main organ perfusion circuit. This configuration supports hemodynamic stability, helps prevent excessive intravascular pressures, and may reduce the risk of tissue edema. The physical connection, priming, and monitoring of the CRRT circuit are explained in detail, along with instructions on how to utilize a Hoffman clamp to simulate physiological venous pressure. When compared to direct in-line circuit integration, representative results suggest that the out-of-circuit approach is associated with reduced graft edema, while maintaining stable circuit pressure and solute clearance. This approach can be easily integrated into other similar perfusion devices in order to improve solute handling while maintaining stable perfusion dynamics.